Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial

Journal:
Nature Medicine
Published:
Affiliations:
19
Authors:
23
Institutions Authors Share
NewAmsterdam Pharma B.V., Netherlands
6.500000
0.28
Monash University, Australia
3.000000
0.13
Baylor College of Medicine (BCM), United States of America (USA)
1.000000
0.04
Imperial College London (ICL), United Kingdom (UK)
1.000000
0.04
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
1.000000
0.04
Cleveland Clinic, United States of America (USA)
1.000000
0.04
Washington University in St. Louis (WUSTL), United States of America (USA)
1.000000
0.04
Centre for Heart Lung Innovation (HLI), Canada
1.000000
0.04
University of Cambridge, United Kingdom (UK)
1.000000
0.04
Universitätsklinikum Leipzig, Germany
1.000000
0.04
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)
1.000000
0.04
Medpace, United States of America (USA)
1.000000
0.04
University of Amsterdam (UvA), Netherlands
0.500000
0.02
Medical University of Lodz (MUL), Poland
0.500000
0.02
John Paul II Catholic University of Lublin (KUL), Poland
0.500000
0.02
University of Milan (UNIMI), Italy
0.500000
0.02
IRCCS MultiMedica, Italy
0.500000
0.02
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
0.500000
0.02
SUNY Downstate Health Sciences University (SUNY Downstate), United States of America (USA)
0.500000
0.02